Deutsche Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Deutsche Bank’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-361,534	Closed	-$38.8M	–	4046
2023 Q1	$38.8M	Buy	361,534 +344,368	+2,006%	+$39.6M	0.02%	584
2022 Q4	$1.89M	Buy	17,166 +3,330	+24%	+$216K	﹤0.01%	1696
2022 Q3	$816K	Sell	13,836 -1,406	-9%	-$64.3K	﹤0.01%	2091
2022 Q2	$430K	Sell	15,242 -1,282	-8%	-$37.2K	﹤0.01%	2697
2022 Q1	$624K	Sell	16,524 -1,690	-9%	-$66.8K	﹤0.01%	2626
2021 Q4	$720K	Buy	18,214 +11,714	+180%	+$367K	﹤0.01%	2614
2021 Q3	$154K	Sell	6,500 -209	-3%	-$4.93K	﹤0.01%	3698
2021 Q2	$165K	Buy	+6,709	New	+$150K	﹤0.01%	3898

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Deutsche Bank's RXDX Position: Q2 2023 in Review

Deutsche Bank sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 361,534 shares — an estimated $38.8M sold.

Deutsche Bank first reported a position in RXDX in Q2 2021 and held it in 8 quarters. The position peaked at $38.8M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Deutsche Bank reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Deutsche Bank sold 361,534 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $38.8M.
Deutsche Bank first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Deutsche Bank's Prometheus Biosciences, Inc. Common Stock position peaked at $38.8M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.